Lv4
424 积分 2023-04-13 加入
Targeting MHC-E as a new strategy for vaccines and immunotherapeutics
2个月前
已完结
Discovery of Cell-Permeable Macrocyclic Cyclin A/B RxL Inhibitors that Demonstrate Anti-tumor Activity in E2F-Driven Cancers
8个月前
已完结
An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response
9个月前
已完结
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
9个月前
已完结
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
9个月前
已完结
Structural mechanism for the recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F
9个月前
已完结
Structural mechanism for the recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F
9个月前
已完结
皖公网安备34019202002308
